Ro, a direct-to-consumer telehealth app for pharmacy services, raised $200 million as part of its latest fundraising round, according to a July 27 news release.
Three notes:
1. Ro will use the funds to double the size of its engineering team to develop remote patient monitoring with integrated devices for chronic disease management, urgent care and at-home testing on its platform.
2. Since launching in 2017, Ro has raised $376 million and expanded its clinical offering to three digital health clinics: Rory for women's health, Roman for men's health and Zero for helping individuals quit smoking.
3. Ro also powered an online, cash pay pharmacy that offers more than 500 generic medications for just $5 per month per drug.
"Telehealth companies like Ro are using technology to address long-standing healthcare disparities that have been exacerbated by COVID-19," said Joycelyn Elders, MD, Ro medical advisor, according to the news release. "By empowering providers to leverage their skills as efficiently and effectively as possible, Ro delivers affordable, high-quality care regardless of a patient's location, insurance status or physical access to physicians and pharmacies."